Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01139138
What this trial is testing

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
The Queen Elizabeth Hospital 49
Testing effectiveness (Phase 2)WithdrawnNCT00954876
What this trial is testing

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Translational Genomics Research Institute
Testing effectiveness (Phase 2)WithdrawnNCT06603818
What this trial is testing

Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Microsatellite Stable Metastatic Colorectal CancerMetastatic Colorectal CancerColorectal Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07011576
What this trial is testing

Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Who this might be right for
Colon CancerRectal CancerColorectal Cancer+1 more
SCRI Development Innovations, LLC 60
Not applicableStudy completedNCT05923450
What this trial is testing

Tumor Deposits in Colorectal Cancers

Who this might be right for
Extranodal Extension
University of Campania Luigi Vanvitelli 243
Testing effectiveness (Phase 2)Looking for participantsNCT06887218
What this trial is testing

5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
The Methodist Hospital Research Institute 57
Testing effectiveness (Phase 2)Study completedNCT00986518
What this trial is testing

T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study

Who this might be right for
Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 5
Testing effectiveness (Phase 2)WithdrawnNCT03576963
What this trial is testing

Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal AdenocarcinomaCpG Island Methylator PhenotypeMetastatic Microsatellite Stable Colorectal Carcinoma+5 more
University of Southern California
Not applicableLooking for participantsNCT04221893
What this trial is testing

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Who this might be right for
Stage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more
University of California, San Francisco 28
Early research (Phase 1)Study completedNCT00598247
What this trial is testing

A Pilot Study of PPX in Women With Metastatic Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
University of Southern California 15
Testing effectiveness (Phase 2)Study completedNCT02651415
What this trial is testing

Phase II Study of Perindopril and Regorafenib in mCRC

Who this might be right for
Metastatic Colorectal Cancer
British Columbia Cancer Agency 12
Testing effectiveness (Phase 2)Study completedNCT03261947
What this trial is testing

Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Who this might be right for
Metastatic Pancreatic CancerColorectal CancerEsophageal Neoplasms+1 more
Millennium Pharmaceuticals, Inc. 101
Not applicableWithdrawnNCT06221423
What this trial is testing

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal CancerRefractory Colorectal Carcinoma
Fudan University
Testing effectiveness (Phase 2)Study completedNCT01051596
What this trial is testing

ABT-888 in Combination With Temozolomide for Colorectal Cancer

Who this might be right for
Colorectal Cancer
Georgetown University 75
Post-approval studies (Phase 4)UnknownNCT00874406
What this trial is testing

Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fudan University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884
What this trial is testing

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Who this might be right for
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more
Haihua Yuan 15
Not applicableStudy completedNCT06414304
What this trial is testing

Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy

Who this might be right for
Colorectal CancerColorectal Cancer MetastaticMSI-H Colorectal Cancer+3 more
OncoAtlas LLC 30
Testing effectiveness (Phase 2)Study completedNCT05480306
What this trial is testing

Phase 2 Study of DKN-01 in Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal AdenocarcinomaColo-rectal Cancer+1 more
Leap Therapeutics, Inc. 188
Not applicableNo Longer AvailableNCT05274204
What this trial is testing

Individual Patient Expanded Access to CA102N

Who this might be right for
Advanced or Metastatic Colorectal Cancer (mCRC)
Holy Stone Healthcare Co., Ltd
Large-scale testing (Phase 3)Ended earlyNCT03300609
What this trial is testing

5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

Who this might be right for
Colorectal AdenocarcinomaRAS Wild TypeStage III Colorectal Cancer AJCC v7+6 more
University of Southern California 4
Next Page